Quotient Gets CE Mark for Its MosaiQ Extended Immunohematology Microarray

Eysins, Switzerland-based biodiagnostics company Quotient has received a CE mark for its MosaiQ extended immunohematology microarray, which combines blood typing and disease screening in a single test.

The new certification increases the range of tests that can be run on the company’s MosaiQ platform, which features antibody screening and antigen typing.

“By enhancing the laboratory’s ability to provide rapid, more comprehensive red blood cell phenotyping, healthcare providers can deliver better matched blood and reduce the risk of transfusion adverse events that may be life-threatening,” the company said.